How bacteria shape infant immunity and long-term health

• New research reveals breast milk contains distinct bacterial communities dominated by Bifidobacteria that directly seed infant gut microbiomes.
• University of Chicago study of 507 samples documented 12 cases where identical bacterial strains appeared in both mother’s milk and infant gut.
• Breast milk microbes produce metabolites like lactate and acetate that lower gut pH and train the developing immune system.
• Maternal antibodies in breast milk regulate gut microbiota and host gene expression, promoting long-term intestinal health.
• Understanding these mechanisms opens new pathways for preventing allergies and optimizing health in early life.

The microbial superhighway: What scientists discovered

For decades, breast milk was viewed primarily as a delivery system for nutrients and antibodies. But recent research published in Nature Communications has fundamentally changed how scientists understand this biological fluid, revealing it as a living ecosystem teeming with bacteria that directly shape an infant’s developing gut microbiome.

Researchers at the University of Chicago analyzed 507 breast milk and infant stool samples from 195 mother-infant pairs as part of the Mothers and Infants LinKed for Healthy Growth study. Their findings demonstrate that breast milk carries its own distinct community of microbes—dominated by Bifidobacteria species—and that these bacteria are transmitted directly to infants during breastfeeding.

This research arrives at a critical moment. The Human Microbiome Project has only begun uncovering the relationship between gut microbes and overall health, while scientists simultaneously explore how early-life microbial exposure influences things like allergy risk and long-term immune function.

The Bifidobacteria connection: More than digestion

The study identified that breast milk contains a distinct bacterial profile dominated by Bifidobacterium longum, B. breve and B. bifidum. More than half of milk samples carried B. longum, a species found in over 98% of infant gut microbiomes.

According to researcher Pamela Ferretti, this finding challenges previous assumptions. Earlier studies using less sophisticated sequencing techniques had primarily identified other bacteria like Staphylococcus and Streptococcus in breast milk. The new metagenomic approach revealed a richer, more complex microbial community.

Dr. Kirsi Jarvinen-Seppo, an immunologist specializing in gut microbiome signaling, explained that Bifidobacteria don’t simply inhabit the gut—they actively communicate with the developing immune system. These bacteria produce large amounts of lactate and acetate, metabolites that lower the pH of the infant gut. This acidic environment makes the intestinal tract less hospitable to pathogens, providing a clear mechanism for immune protection.

Training the immune system: Chemical signals that shape tolerance

Beyond pathogen protection, gut bacteria produce metabolites that support production of specific immunoglobulins, the antibodies that form the immune system’s defense network. More significantly, bacterial signals prompt immune cells to produce regulatory T cells—a subset of lymphocytes whose levels are shaped directly by the composition of the gut microbiota.

Jarvinen-Seppo emphasized that these regulatory T cells function as the immune system’s instructors, determining whether the body should respond to environmental signals or maintain tolerance. This mechanism represents a key link between early microbial exposure and the balance between immune reactivity and tolerance later in life.

Antibodies and long-term health: The lasting impact

Research on maternal antibodies in breast milk has demonstrated that these immune factors promote long-term intestinal homeostasis by regulating both the gut microbiota and host gene expression. Breastfed infants typically have up to 90% Bifidobacteria in their gut flora, compared to significantly lower levels in formula-fed infants.

The study documented 12 instances where identical bacterial strains were found in a mother’s breast milk and her infant’s gut—strong evidence of vertical transmission during breastfeeding. Some of these shared strains were beneficial commensal species that help digest human milk sugars and support healthy gut development. Others were pathobionts like E. coli and Klebsiella pneumoniae that can live harmlessly in healthy individuals but have the potential to cause infection under certain conditions.

Researchers noted that all mothers and infants in the study were healthy, indicating that microbial diversity in breast milk does not inherently signal disease but rather reflects the complex ecosystem transferred during breastfeeding.

The window of opportunity: Implications for prevention

Scientists now recognize a critical “window of opportunity” in early life during which interventions altering the gut microbiota can induce long-term effects. Breastfeeding shapes the gut microbiota both directly, through exposure to milk microbes, and indirectly, through maternal factors like human milk oligosaccharides, secretory IgA and antimicrobial compounds that affect bacterial growth and metabolism.

The potential of breast milk to modulate the offspring’s early gut microbiota represents a promising tool for allergy prevention. Evidence demonstrates that the neonate’s gut microbiota composition and metabolism play essential roles in allergic disease risk, making early microbial exposure a potential intervention point.

Looking forward: What this means for public health

This research nearly doubles the number of metagenomic breast milk samples publicly available for scientific study. Researchers plan to expand their analysis using multi-omic approaches that include examining metabolites like human milk oligosaccharides and environmental factors such as PFAS and antimicrobial resistance that can be passed through milk.

The ultimate goal, Ferretti noted, is to examine longer health trajectories and determine whether factors in breast milk and early life predict health outcomes later in life. As scientists continue mapping this microbial superhighway, the implications for vaccine safety, allergy prevention and immune health remain profound—suggesting that the first sips of life contain far more than nutrition alone.

Sources for this article include:

ContemporaryPediatrics.com

FrontiersIN.org

PubMed.com

BiologicalSciences.UChicago.edu